Introduction
Macrophages are a group of heterogeneous cells that play a wide range of roles in maintaining the internal homeostasis (Wynn et al., 2013) . When inadvertently activated under stress conditions, however, macrophages can contribute to the pathogenesis of human diseases (Hotamisligil, 2006; Qian and Pollard, 2010; Weber et al., 2008) . A paradigm of macrophage-dependent pathophysiological process is the initiation and perpetuation of chronic inflammation, which is considered pivotal to the disruption of physiologic integrity of tissues and organs. For instance, it has been demonstrated that human atherosclerotic lesions abound with macrophages (Gown et al., 1986) . Conversely, systemic depletion of macrophages stalls the development of atherosclerosis in mice (Stoneman et al., 2007) .
Lipopolysaccharide (LPS) engages the pattern recognition receptor TLR4 to launch a strong pro-inflammatory reaction in macrophages. LPS induced pro-inflammatory transcription is programmed by NF-κB, the master regulator of chronic inflammation (Smale, 2011) . Accumulating evidence has helped fuel the notion that NF-κB dependent pro-inflammatory transcription is a function of chromatin structure modulated by the epigenetic machinery: a chromatin wrapped with acetylated histones H3 and H4 and methylated histone H3 lysine 4 (H3K4) generally facilitates NF-κB mediated transcriptional activation (Natoli, 2009) . Recent investigations have given support to this model. For instance, Austenaa et al demonstrate that the H3K4 methyltransferase (HMT) Mll4/Wbp7 is required for LPS-induced gene expression in macrophages (Austenaa et al., 2012) . Wang et al, on the other hand, show that another HMT (Mll1) is indispensible for NF-κB mediated transcription in response to TNF-α (Wang et al., 2012) . Currently, it is not completely clear whether NF-κB is self-sufficient in terms of engaging various epigenetic factors in transcriptional regulation or a co-factor is necessary to bridge NF-κB and the epigenetic machinery.
Myocardin related transcription factor A (MRTF-A) is known to function as a co-activator for SRF (Wang et al., 2002) , Smad3 (Morita et al., 2007) , and Sp1 . Our previous study has found that MRTF-A could drive the transcription of adhesion molecules in vascular endothelial cells by directly interacting with NF-κB/p65 (Fang et al., 2011) . The ability of MRTF-A to steer transcriptional events is derived in part
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Results
MRTF-A is necessary for LPS-induced pro-inflammatory transcription in macrophages
We have previously shown that MRTF-A interacted with NF-κB to activate ICAM-1 expression in vascular endothelial cells (Fang et al., 2011) . Since NF-κB is the central mediator of LPS-induced pro-inflammatory transcription in macrophages, we tackled the question as to whether MRTF-A would be necessary for this process. Over-expression of MRTF-A enhanced the κB reporter activity in response to LPS treatment in both murine (RAW264.7) and human (THP-1) macrophages (Fig.1A ). Compared to MRTF-A, MRTF-B, another member of the MRTF family, was a much weaker activator of the κB reporter (Fig.S1A ). Over-expression of MRTF-A also significantly up-regulated the synthesis of endogenous pro-inflammatory mediators in macrophages treated with LPS both at the mRNA level as assayed by qPCR (Fig.1B) and at the protein level as measured by ELISA (Fig.1C ).
In contrast, over-expression of a dominant negative (DN) form of MRTF-A, which can interact with p65 but lacks the transactivation domain (Fang et al., 2011) , suppressed activation of the κB reporter ( Fig.S1B ) and dampened the production of endogenous pro-inflammatory mediators (Fig.S1C, S1D ). Immunofluorescence staining reveals that treatment with LPS caused a rapid accumulation of MRTF-A along with NF-κB/p65 in the nucleus in RAW264.7 cells (Fig.S1E ).
Previous studies have indicated that MRTF-A delegates transactivation to the epigenetic machinery (Fang et al., 2011; Hanna et al., 2009; Yang et al., 2013; Zhang et al., 2007) . Therefore, we examined whether the attenuation of transcriptional activation of NF-κB target genes as a result of MRTF-A silencing could be correlated to a repressed chromatin structure.
MRTF-A knockdown in RAW264.7 led to a decrease in the enrichment of acetylated histone H3 (AcH3, Fig.S3A ) and acetylated histone H4 (AcH4, Fig.S3B ) on the gene promoters.
Similarly, we noted a reduction in the accumulation of AcH3 (Fig.S3C) and AcH4 (Fig.S3D) in MRTF-A deficient MEF cells in comparison to WT MEF cells. Moreover, dimethylated histone H3K4 (Fig.4A, 4C ) and trimethylated H3K4 (Fig.4B, 4D) were erased from the NF-κB target promoters when MRTF-A was silenced. Finally, the occupancies of Brg1 and Brm, two core components of the mammalian chromatin remodeling complex known to participate in LPS-induced transactivation of pro-inflammatory mediators (Ramirez-Carrozzi et al., 2006) , were also significantly down-regulated in RAW264.7 cells without MRTF-A (Fig.S3E, S3F ). Taken together, these data confirm our hypothesis that MRTF-A might modulate LPS-induced pro-inflammatory transactivation by altering the chromatin structure.
MRTF-A recruits the COMPASS proteins to activate LPS-induced pro-inflammatory transcription
The complex associated with SET1, or COMPASS, has been shown to mediate histone H3K4 methylation in mammals (Shilatifard, 2012) . Having observed that MRTF-A deficiency was associated with the disappearance of H3K4Me2 and H3K4Me3 from the promoter regions, we decided to examine whether MRTF-A could recruit COMPASS to activate LPS-induced pro-inflammatory transcription. Indeed, there was an interaction between MRTF-A and COMPASS proteins as confirmed by immunoprecipitation (Fig.5A ).
In LPS-treated macrophages, we observed significant recruitment of several COMPASS components including ASH2, WDR5, and SET1 with a similar kinetics as MRTF-A and p65 (Fig.5B ). More importantly, Re-ChIP data suggest that MRTF-A could form a complex with ASH2 ( Fig.5C ), WDR5 (Fig.5D ), and SET1 (Fig.5E ) on the gene promoters in response to LPS stimulation. On the contrary, depletion of MRTF-A significantly crippled the binding of COMPASS proteins (Fig.5F ), indicating that MRTF-A is responsible for COMPASS proteins (Fig.7F ), indicating that COMPASS is required for optimal chromatin positioning of NF-κB.
Discussion
Chromatin is the hub where different signals and inputs are being integrated and processed to guide transcription in mammalian cells. Recent investigations have given rise to the model wherein NF-κB dependent pro-inflammatory transcription is spatiotemporally dictated by chromatin organization (Natoli, 2011) . We provide new evidence here that MRTF-A is a de novo co-factor of NF-κB in macrophages commanding a histone H3K4 methyltransferase complex to mediate LPS-induced pro-inflammatory transcription.
We find here that MRTF-A is both necessary and sufficient to potentiate the transactivation of several pro-inflammatory mediators in cultured cells. We also find that MRTF-A deficiency attenuates inflammation in a mouse of colitis, which is consistent with several previous reports showing that MRTF-A ablation alleviates pulmonary and cardiac injury and fibrosis (Small et al., 2010; Zhou et al., 2013) . This could be potentially be interpreted as impaired macrophage activation supported by the in vitro observation.
Alternatively, our previous investigation has assigned a role for MRTF-A in mediating the interaction between endothelial cells and circulating innate immune cells (Fang et al., 2011) .
Since the recruitment of circulating immune cells plays an important role in the pathogenesis of colitis (Sans et al., 1999) , the diminished inflammatory response in MRTF-A deficient mice could also be explained by a reduction of leukocyte adhesion and/or chemotaxis.
Thirdly, NF-κB has been shown to program macrophage polarization favoring a pro-inflammatory M1 phenotype (Tugal et al., 2013) . Mounting evidence supports a role for MRTF-A in directing differentiation/trans-differentiation in smooth muscle cells (Hinson et al., 2007) , skeletal muscle cells (Selvaraj and Prywes, 2003) , epithelial cells (Morita et al., 2007) , megakaryocytes (Gilles et al., 2009) , and fibroblast cells (Crider et al., 2011) . We therefore speculate that MRTF-A deficiency could potentially skew the macrophages to an anti-inflammatory M2 phenotype. Clearly, further studies are warranted to reconcile these different scenarios and delineate a more definitive role for MRTF-A.
One major finding in this report is that the interplay between MRTF-A and NF-κB/p65 appears to extend both ways. MRTF-A depends on p65 to gain access to the chromatin while at the same time actively influencing the nuclear accumulation and target binding affinity of p65 (Figure 3 and Figure S2 ). The ability of MRTF-A to modulate the chromatin positioning of p65 could be easily attributed to the fact that MRTF-A interacts with histone modifying enzymes (COMPASS, Figure 5 ) and remodeling proteins (Brg1/Brm, Figure S3 ) and in so doing creates a "friendly" conformation of chromatin for p65 to bind. This model is further supported by our previous observation that silencing of Brg1/Brm impedes the binding of p65 to the promoters of adhesion molecules and our current observation that silencing the COMPASS complex disrupts the kinetics of p65 on the promoters of pro-inflammatory mediators (Figure 7) . Conversely, depletion of p65 negatively impacted the binding of COMPASS complex and the deposition of acetylated and methylated histones (Fig.6 ). It is of particular importance to note that our data also suggest MRTF-A could directly regulate nuclear localization of p65. Thus, these data, when taken together, seem to argue that epigenetic modulation of pro-inflammatory transcription takes place in a feed-forward manner: co-factors (e.g., MRTF-A) facilitates the translocation of sequence-specific transcription factors (e.g., p65). The latter then recruit co-factors to DNA in a context-dependent manner. Consequently, co-factors enlist histone modifying enzymes and chromatin remodelers to re-organize the chromatin structure bringing more TFs (Natoli, 2009 ).
Our data also implicate MRTF-A as a coordinator of the crosstalk between histone acetyltransferases (HATs) and methyltransferases (HMTs, Figure S3 ). It is not entirely clear at this point how this is achieved. The most straightforward explanation is that MRTF-A interacts with p300 and COMPASS and as such could act as a mediator. It is, however, equally plausible that MRTF-A may rely on other means to broker this dialogue. For instance, both HATs and HMTs are known to prefer certain chromatin structure to exert their effects (Holbert et al., 2007; Krajewski and Reese, 2010) . Therefore, MRTF-A could, independent of its interaction between COMPASS and p300, recruit Brg1/Brm to re-organize the chromatin to establish a "comfort zone" for HATs and HMTs to engage on. Hopefully, ChIP-seq analyses on the binding patterns of MRTF-A, Brg1/Brm, COMPASS, and p300 in the context of LPS-induced pro-inflammatory would shed more light on the mechanism whereby MRTF-A helps different histone enzymes navigate the genome.
An interestingly observation in the present study is that both primary response genes (e.g., Tnf-α) and secondary response genes (e.g., Il-6) seem to be affected by the NF-κB/MRTF-A/COMPASS complex. However, cautions need to taken to interpret these data. Chromatin structure is determined cumulatively by the presence of different histone modifications, remodeling proteins, and histone variants. Although COMPASS complex may bind to both early and late response genes, the kinetics is quite different (Fig.5) . In addition, the presence of COMPASS does not necessarily mean that it is the rate-limiting factor for the transcription of its target genes. Instead, its role needs to evaluated in the context of other histone modifying enzymes (e.g., p300) and chromatin remodelers (e.g., Brg1) that can also be recruited by MRTF-A. Further complicating the role of COMPASS in the current model is that the action of COMPASS can be antagonized by demethylases, which are not examined in the current report but are nonetheless involved in NF-κB dependent transcription (Fuchs, 2013) . Again, more investigations are needed to more clearly define the role of COMPASS in pro-inflammatory transcription.
In essence, our report indicates that the NF-κB/MRTF-A duo is responsible for epigenetic regulation of pro-inflammatory transcription induced by LPS (Fig.7G) . However, it is paramount not overstate this conclusion since there still several unsolved issues regarding the current model. First, it cannot be ignored at this point that other transcription factors (e.g., SRF and AP-1) might also participate in this process by modulating chromatin structure and/or influencing the access of NF-κB/MRTF-A. In fact, our previous report has suggested such a role for SRF in the regulation of ICAM-1 activation in endothelial cells (Fang et al., 2011) . Second, the current study focuses entirely on the proximal promoter region while the role of distal regulatory elements is left unaddressed. Numerous investigations have established that epigenetic events taking place at enhancers are key to inflammation-related transcription (Arvey et al., 2014; Ghisletti et al., 2010; Li et al., 2013) .
It is possible that different isoforms of MRTFA might interact with different sites to drive pro-inflammatory transcription. Finally, MRTF-A activity is impacted by actin filament reorganization as a result of RhoA activation (Olson and Nordheim, 2010) . Several reports have suggested that RhoA signaling may be transmitted to the nucleus to influence differential recruitment of epigenetic factors and gene expression (Helms et al., 2007; Kim et al., 2005; Ling and Lobie, 2004) . The question as to whether MRTF-A serves the moderator linking cytoskeleton dynamics and epigenetic regulation of pro-inflammatory is certainly worth further investigation.
In summary, our data as summarized here reaffirm the role of MRTF-A as a key epigenetic orchestrator steering LPS-induced, NF-κB-dependent pro-inflammatory transcription in macrophages. A lingering question of the current report is whether the proposed model is cell-specific, ie, restricted to macrophages. MRTF-A has been implicated in the regulation of smooth muscle cell phenotypic modulation and epithelial-to-mesenchymal transition (EMT), both of which involve extensive chromatin re-organization of MRTF-A target genes (Alexander and Owens, 2012; Tam and Weinberg, 2013) . Tissue-specific animal models of MRTF-A deficiency would help clarify this issue and enable us better understand the cell-autonomous role of MRTF-A for the ultimate goal of rationalized development of MRTF-A-targeting therapeutic strategies.
Materials and Methods
Cell culture
Murine macrophages RAW264.7 (ATCC) and human monocytic/macrophage-like cells THP-1 (ATCC) were maintained in DMEM supplemented with 10% FBS. Murine bone marrow-derived macrophages (BMDM) were isolated and cultured as described before (Xu et al., 2012) . Mouse embryonic fibroblast (MEF) cells were isolated from wild type and MRTF-A knockout mice as described before (Sun et al., 2006) . LPS was purchased from Sigma.
Plasmids, transfection, and reporter assay
Expression constructs for MRTF-A (Cen et al., 2003) , ASH2, WDR5, and SET1 (Wu et al., 2008) as well as the κB reporter (Rosette and Karin, 1995) have been described before.
siRNA sequences are listed in supplemental Table 1 . Transient transfections were performed with Lipofectamine LTX (Invitrogen). An EGFP expression construct was included in each well to monitor transfection efficiency. Luciferase activities were assayed 24-48 hours after transfection using a luciferase reporter assay system (Promega). Luciferase activities were normalized by both protein concentration and GFP fluorescence. Experiments were routinely performed in triplicate wells and repeated three times.
Animal Studies
All animal protocols were approved by the intramural Ethics Committee on Animal Studies and in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals. MRTF-A deficient mice have been described previously (Sun et al., 2006) . To induce colitis, 6-8 week-old MRTF-A deficient mice and their littermates were given 2% (w/v) DSS (MP Biomedicals) in their drinking water for 7 days.
Protein extraction, Immunoprecipitation, Western Blotting and Gel Shift Assay
Whole cell lysates were obtained by re-suspending cell pellets in RIPA buffer with freshly added protease inhibitor tablet (Roche). Nuclear proteins were prepared with the NE-PER Kit (Pierce) following manufacturer's recommendation. Specific antibodies or pre-immune IgGs (P.I.I.) were added to and incubated with cell lysates overnight before being absorbed by Protein A/G-plus Agarose beads (Santa Cruz). Precipitated immune complex was released by boiling with 1X SDS electrophoresis sample buffer. Western analyses were performed with anti-β-actin (Sigma), anti-MRTF-A, anti-p65, anti-lamin B, anti-α-tubulin (Santa Cruz), anti-ASH2, anti-WDR5, and anti-SET1 (Bethyl Laboratories) antibodies. Electrophoresis mobility shift assay (EMSA) was performed essentially as described before (Yang et al., 2013) .
ChIP and Re-ChIP assay
ChIP assays were performed essentially as described before Tian et al., 2013) . Aliquots of lysates containing 200 μ g of nuclear protein were used for each immunoprecipitation reaction with anti-MKL1, anti-p300, anti-p65, anti-Brg1, anti-Brm (Santa Cruz), anti-ASH2, anti-WDR5, anti-SET1 (Bethyl Laboratories), anti-acetylated H3, anti-acetylated H4, anti-acetyl H3K9, anti-acetyl H3K14, anti-acetyl H3K18, anti-acetyl H3K27, anti-dimethylated H3K4, and anti-trimethylated H3K4 (Millipore/Upstate). For Re-ChIP, immune complexes were eluted with the elution buffer (1% SDS, 100mM NaCO3), diluted with the Re-ChIP buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris pH 8.1), and subject to immunoprecipitation with a second antibody of interest. Precipitated genomic DNA was amplified by real-time PCR with primers listed in supplemental Table 2 .
RNA extraction and Real-time PCR
RNA was extracted using an RNeasy RNA isolation kit (Qiagen). Reverse transcriptase reactions were performed using a SuperScript First-strand synthesis system (Invitrogen).
Real-time PCR reactions were performed on an ABI STEPONE Plus (Life Tech) with primers and Taqman probes purchased from Applied Biosystems.
Histology
Immunohistochemistry was performed as previously described . Paraffin sections of colon were processed by standard techniques. Longitudinal sections of 5 mm thick were stained with hematoxylin and eosin (H&E). Pictures were taken using an Olympus IX-70 microscope and examined by two independent pathologists using a scoring system as previously described (Zaki et al., 2011) .
Immunofluorescence microscopy
Formaldehyde fixed cells were blocked with 5% BSA, and incubated with indicated primary antibodies overnight. After several washes with PBS, cells were incubated with FITC-labeled secondary antibodies (Jackson) for 30 minutes. DAPI (Sigma) was added and incubated with cells for 5 minutes prior to observation. Immunofluorescence was visualized on a co-focal microscope (LSM 710, Zeiss). For quantification, 30 cells were counted in triplicate culture dishes for each condition.
Enzyme-linked immune absorbance assay (ELISA)
Supernatants containing pro-inflammatory mediators were collected from cultured cells or tissue lysates and ELISA was performed to measure IL-1, IL-6, MCP-1, and TNF-α using commercially available kits (Ray Biotech, Norcross, GA).
Statistical Analysis
Two-sided T-test (for experiments involving two groups) or one-way ANOVA with post-hoc Scheffe analyses (for experiments involving with at least three groups) were performed using an SPSS package. p values smaller than .05 were considered statistically significant (*). RAW264.7 cells were transfected with indicated siRNAs followed by treatment with LPS.
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